FDA grants de novo authorization to AI-powered Scanly Home OCT device
The FDA granted de novo marketing authorization to Notal Vision for the patient self-operated AI-powered Scanly Home OCT device, according to a press release.
Stay updated with breaking news from Notal Vision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA granted de novo marketing authorization to Notal Vision for the patient self-operated AI-powered Scanly Home OCT device, according to a press release.
Yesterday SPIE the international society for optics and photonics recognized the most innovative new optics and photonics products with the industryfocused Prism Awards.
The Global Optical Coherence Tomography (OCT) Industry has achieved a significant milestone, with a market size of US$ 1,311.70 million in 2023. A promising future lies ahead as the OCT market is expected to soar to US$ 3,250.70 million by 2033, driven by a robust compound annual growth rate (CAGR) of 9.5% from 2023...
The size of the global optical coherence tomography market was estimated at US$ 1.1 billion in 2021 and is anticipated to grow to US$ 1.2 billion in 2022. The overall demand for optical coherence tomography is also expected to increase at an impressive CAGR of 9.8% from 2022 to 2032, reaching over US$ 3.0 Bn by the...
Optical Coherence Tomography Market totaling over US$ 3.0 Bn by the end of 2032 | FMI